SCHEMBL9037704

SCHEMBL9037704

CCCCCCCCCCCCCCCCCCN1CSc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 4/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM1A O60341 1/20 0.42
PDF Q9HBH1 2/20 0.41
CES1 P23141 2/20 0.41
CDC25A P30304 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HTT P42858 1/20 0.40
EEF2K O00418 1/20 0.39
ALDH2 P05091 1/20 0.39
ALDH3A1 P30838 1/20 0.39
HTR1A P08908 1/20 0.38
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37
FAAH O00519 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9064444 1.00 LMNA (0.43) LMNAKDM4EALDH1A1CYP1A2CYP2D6
SCHEMBL9722988 1.00 LMNA (0.43) LMNAKDM4EALDH1A1CYP1A2CYP2D6
SCHEMBL29306541 1.00 LMNA (0.43) LMNAKDM4EALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL9694372 0.98 ALDH1A1 (0.45) LMNAKDM4EALDH1A1CYP1A2CYP2D6
Bromide SCHEMBL9625797 0.98 ALDH1A1 (0.45) LMNAKDM4EALDH1A1CYP1A2CYP2D6
Iodide SCHEMBL9038446 0.98 LMNA (0.42) LMNAKDM4EALDH1A1CYP1A2CYP2D6
SCHEMBL4304928 0.98 KDM1A (0.43) LMNAKDM4EALDH1A1CYP1A2CYP2D6
SCHEMBL29878442 0.93 KDM1A (0.48) LMNAKDM4EALDH1A1CYP1A2CYP2D6
SCHEMBL9715453 0.93 KDM1A (0.48) LMNAKDM4EALDH1A1CYP1A2CYP2D6
SCHEMBL27817030 0.92 KDM1A (0.40) LMNAKDM4EALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0262343-B1 N-alkylated quaternary nitrogen-containing heterocycles, process for their preparation and their use in pharmaceutical compositions PUETTER MEDICE CHEM PHARM (DE) 1996-01-03 EP claimed
EP-0161987-B1 ORGANIC AMPHIPHILE COMPLEXES FOR CHARGE TRANSFER, CONDUCTORS FOR ELECTRICITY OR PRECURSORS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1988-11-23 EP disclosed
EP-0161987-A1 Organic amphiphile complexes for charge transfer, conductors for electricity or precursors COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1985-11-21 EP disclosed